-
酸棗仁油的超臨界CO2萃取
...C02萃取酸棗仁爲鼠李科落葉灌木或喬木植物酸棗Ziziphus血MiH.var.spinosa(Bunge)HuexH.F.Chou的乾燥成熟種子。酸棗仁味甘、酸,性平,能養心益肝、安神斂汗。主要用於血虛之心悸、失眠及體虛之自汗、盜汗。本文對酸棗仁油的超...
-
淺談Internet上醫學信息資源的獲取途徑
...2Internet上的專業醫學文獻檢索 2.1Medline(http://www.nlm.mih.gov)世界權威生物醫學文獻數據庫MEDLINE數據庫是由美國國立醫學圖書館建立和維護的,收錄了世界上4800種以上的醫學及生物學期刊。該數據庫涵蓋基礎生命科學、臨牀...
-
ResequencingGenomicDNAofPatientsWithSevereHypertriglyceridemia(MIM144650)
...einlipase.ClinBiochem.2002;35:125–130.ThomasPD,CampbellMJ,KejariwalA,MiH,KarlakB,DavermanR,DiemerK,MuruganujanA,NarechaniaA.PANTHER:alibraryofproteinfamiliesandsubfamiliesindexedbyfunction.GenomeRes.2003;13:2129–2141.ThomasPD,KejariwalA,GuoN,MiH,CampbellMJ,MuruganujanA,Lazareva-UlitskyB....
-
Acriticalrolefortheprogrammeddeathligand1infetomaternaltolerance
...leswereinjectedi.p.6.5,8.5,10.5,and12.5dpcwiththeblockinganti-mousePDL1mAb(MIH6)atdosagesof500μg,500μg,250μg,and250μg,respectively.Inparallelsetsofexperiments,groupsofmicewereinjectedwithanti-PDL2(TY25)(32)oranti-B7.2(GL1)(33)antibodieswiththesamedosagesandregimen.HistologyAtpredeterminedinterva...
-
Microchimerismmaintainsdeletionofthedonorcell–specificCD8+Tcellrepertoire
...eloflymphohematopoieticcellengraftmentacrossastrongminorhistocompatibility(miH)antigenmismatchinadultmice(28,29).WeuseddonorsplenocytesoftransgenicH8miceconstitutivelyexpressingtheH-2Db-restrictedGP33epitope(aminoacids33to41)ofthelymphocyticchoriomeningitisvirus(LCMV)glycoprotein.TheengraftmentofH8s...
-
亞健康狀態研究進展
...性、心理性和人際交往性三種亞健康狀態。2003年10月美國MIH公佈了全球健康的十四大挑戰,其中有兩條就是專門針對亞健康狀態提出的。本文就近年來的研究進展綜述如下。 1亞健康狀態的概念 我國古代醫家早在兩千多...
-
定向分化神經前體細胞移植治療脊髓損傷
...nthedevelopingspinaleord[J].ProcNatlAcadSciUSA,1998,7:3996-4001.[6]MiH,BarresBA.Purificafionandcharacterizationofastrocyteprecursorcellsinthedevelopingratopticnerve[J].JNeurosci,1999,3:1049-1061.[7]RaoMS,Mayer-ProschelM.Glial-restrictedprecursorsarederivedfrommultipotentneuroepitheli...
-
第四節 下丘腦-垂體內分泌功能紊亂的臨牀生化
...刺激素抑制激素(melanocytestimulatinghormone-in-hibitinghormone,MIH)MSH ㈢下丘腦-腺垂體激素分泌的調節 下丘腦-腺垂體激素分泌的調節,主要受腺垂體各種促激素作用的靶腺分泌的激素之反饋調節(長反饋),其中甲狀腺激...
-
BlockadeoftheInteractionBetweenPD-1andPD-L1AcceleratesGraftArterialDiseaseinCardiacAllografts
...lonalantibody(mAb)againstPD-L1inthesemodels.MethodsReagentsAnti-mousePD-L1(MIH5,ratimmunoglobulinG2a)mAbwasgeneratedasdescribedpreviously.13Anti-mousePD-1mAb,fluoresceinisothiocyanate(FITC)-conjugatedanti-mouse-smoothmuscleactin(SMA)mAb,anti-mouseCD4mAb,FITC-conjugatedanti-mouseCD4mAb,anti-mouseCD8a...
-
DailyconsumptionofIndianspinach(Basellaalba)orsweetpotatoeshasapositiveeffectontotal-bodyvitaminAstoresinBangladeshimen
...desh(ICDDR,B):CentreforHealthandPopulationResearch,Dhaka,Bangladesh(KMJ,FH,MIH,andGJF)2SupportedbytheUSDepartmentofAgriculture(grantno.98-35200-6099)andtheMicronutrientInitiative(grantno.5600-0001-04-300.Retinylpalmitateandß-caroteneweredonatedbyRocheVitamins(Parsippany,NJ),andsweetpotatoeswere...
-
CD4+CD25+Tcellsprotectagainstexperimentallyinducedasthmaandalterpulmonarydendriticcellphenotypeandfunction
...odiestoCD80(16-10A1),CD86(GL1),MHCclassIII-Ek(14-4-4s),ICOS-L(HK5.3),B7-H1(MIH5),andB7-DC(TY25).TcellsubsetswereexaminedusingmAbstoCD4(RM4-5),CD25(PC61or7D4),andICOS(7E.17G9),andproliferationwasfollowedusingCFSE(Invitrogen).Deadcellswereexcludedusingtheviabilitydye7-amino-actinomycinD(7-AAD).Allanti...
-
ImmunostimulatoryoligonucleotidesblockallergicairwayinflammationbyinhibitingTh2cellactivationandIgE-mediatedcytokineinduction
...udedanti-CD11c(HL-3),anti-B220(RA3-6B2),anti–I-Ad(AMS-32.1),anti–PD-L1(MIH5),anti–PD-1(J43),anti-CD40(3/23),anti-CD80(16-10A1),anti-CD86(GL1),anti-ICOS(7E.17G9;allfromBDBiosciences),anti–PDCA-1(MiltenyiBiotec),andanti–PD-L2(TY25;eBioscience).InvitroincubationofairwayAPCsandTcells.Atwofoldd...
-
ExpressionofProteinKinaseCKinAstroglialCellsofNormalandNeovascularizedRetina
...chiaroPA:Retinalandchoroidalneovascularization.JCellPhysiol2000,184:301-310MiH,HaeberleH,BarresBA:Inductionofastrocytedifferentiationbyendothelialcells.JNeurosc2001,21:1538-1547YamadaH,YamadaE,AndoA,SeoMS,EsumiN,OkamotoN,VinoresM,LaRochelleW,ZackDJ,CampochiaroPA:Platelet-derivedgrowthfactor-A-induce...
-
心肌梗塞
...管再通之後再維持1/2~1小時。如用rtPA先注入10mg,繼而30mih輸注40mg,最後1hr內再輸注50mg。本法療效較好,用藥量較小,但要有造影的設備和技術,準備和操作過程會耽誤給藥時間,故目前已較靜脈給藥法少用。用藥物溶解血栓...